Risk Factors Associated with Impaired Ovarian Reserve in Young Women of Reproductive Age with Crohn’s Disease
Open Access
- 30 April 2020
- journal article
- research article
- Published by Korean Association for the Study of Intestinal Diseases in Intestinal Research
- Vol. 18 (2), 200-209
- https://doi.org/10.5217/ir.2019.00103
Abstract
Background/Aims: Crohn's disease (CD) primarily affects young female adults of reproductive age. Few studies have been conducted on this population's ovarian reserve status. The aim of study was to investigate potential risk factors associated with low ovarian reserve, as reflected by serum anti-Mullerian hormone (AMH) in women of reproductive age with CD. Methods: This was a case-control study. Cases included 87 patients with established CD, and healthy controls were matched by age, height and weight in a 1:1 ratio. Serum AMH levels were measured by enzyme-linked immunosorbent assay. Results: The average serum AMH level was significantly lower in CD patients than in control group (2.47 +/- 2.08 ng/mL vs. 3.87 +/- 1.96 ng/mL, respectively, P<0.001). Serum AMH levels were comparable between CD patients and control group under 25 years of age (4.41 +/- 1.52 ng/mL vs. 3.49 +/- 2.10 ng/mL, P=0.06), however, serum AMH levels were significantly lower in CD patients over 25 years of age compared to control group (P<0.05). Multivariable analysis showed that an age greater than 25 (odds ratio [OR], 10.03; 95% confidence interval [CI], 1.90-52.93, P=0.007), active disease state (OR, 27.99; 95% CI, 6.13-127.95, P<0.001) and thalidomide use (OR, 15.66; 95% CI, 2.22-110.65, P=0.006) were independent risk factors associated with low ovarian reserve (serum AMH levels < 2 ng/mL) in CD patients. Conclusions: Ovarian reserve is impaired in young women of reproductive age with CD. Age over 25 and an active disease state were both independently associated with low ovarian reserve. Thalidomide use could result in impaired ovarian reserve.Keywords
Funding Information
- National Natural Science Foundation of China (81470821,81270473,81670607,81970483)
This publication has 48 references indexed in Scilit:
- Anti-inflammatory effect of thalidomide in paraquat-induced pulmonary injury in miceInternational Immunopharmacology, 2013
- Assessment of ovarian function with anti-Müllerian hormone in systemic lupus erythematosus patients undergoing hematopoietic stem cell transplantFertility and Sterility, 2009
- The Effect of Restorative Proctocolectomy on Sexual Function, Urinary Function, Fertility, Pregnancy and Delivery: A Systematic ReviewDiseases of the Colon & Rectum, 2007
- A systematic review of tests predicting ovarian reserve and IVF outcomeHuman Reproduction Update, 2006
- Female Infertility After Ileal Pouch-Anal Anastomosis for Ulcerative ColitisDiseases of the Colon & Rectum, 2004
- Fertility after ileal pouch–anal anastomosis in women with ulcerative colitisBritish Journal of Surgery, 1999
- Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD).Gut, 1996
- Incidence of Ulcerative Colitis and Indeterminate Colitis in Four Counties of Southeastern Norway, 1990–93 A Prospective Population-Based StudyScandinavian Journal of Gastroenterology, 1996
- The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell culturesClinical and Experimental Immunology, 1995
- Crohn's disease and pregnancy.Gut, 1984